Furthering its role as a tumour suppressor, an RNA-interference library screen identified PITX1 as a potent inhibitor of Rat sarcoma-mitogen activated protein kinase (RAS-MAPK) signalling through transcriptional upregulation of RASAL1 (30). Here, PITX1 is linked to neoplasm.